查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830980

空心胶囊市场

Empty Capsules Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

空心胶囊市场预计将大幅成长，从 2024 年的 77.9 亿美元增加到 2031 年的 136.8 亿美元，预计 2025 年至 2031 年期间的复合年增长率为 8.5%。

分析师观点：本报告概述了基于空胶囊市场当前趋势的成长机会及其在预测期内的预期影响。市场成长的主要驱动力包括老年人口的成长、製药、营养保健品和化妆品产业对空胶囊的需求增加，以及消费者对胶囊而非药片的日益偏好。老年人群通常患有慢性疾病，是製药商关注的重点。老年人倾向于选择胶囊，因为它们更容易吞嚥、溶解更快、且引起的胃肠不适更少。然而，原材料成本上涨以及对胶囊生产中使用的动物性成分的文化或宗教担忧等挑战可能会阻碍市场成长。此外，原料供应有限、对明胶生产商的严格监管以及饮食限制也对市场扩张构成挑战。

市场概览：推动空心胶囊市场成长的因素包括胶囊作为首选药物递送方式的日益普及，以及胶囊供应商和明胶製造商之间的策略合作伙伴关係。此外，研发活动、临床试验、新产品的推出以及胶囊递送技术的进步预计将显着影响未来几年的市场预测。例如，2019年11月，Qualicaps, Inc. 在2019年世界製药原料药（CPHI）全球大会上推出了硬胶囊剂型。

策略洞察市场驱动力：蓬勃发展的营养保健品和膳食补充剂行业推动市场扩张一项题为「营养保健品联繫：一站式揭开完整营养解决方案」的研究报告称，2021 年全球营养保健品市场价值为 4545.5 亿美元，预计 2021 年至 2030 年的复合年增长率为 9.0%。此外，美国国际贸易管理局预测，到 2023 年，印度将占全球营养保健品市场价值的约 3.5%，印度营养保健品产业预计将从 2020 年的约 40 亿美元扩大到 2025 年的 180 亿美元。营养保健品和补充剂行业提供维生素、矿物质、草药萃取物、益生菌和其他生物活性化合物，这些通常需要封装以方便食用。空心胶囊作为一种高效且适应性强的成分输送系统，使製造商能够生产出各种产品。它们使製造商能够根据特定的成分、剂量和目标群体定製配方。这种适应性在营养保健品和膳食补充剂领域至关重要，因为不同的产品需要不同的剂量和成分组合。因此，填充营养保健品或膳食补充剂的胶囊可以帮助製造商满足消费者对品质、便利性和功效的需求，从而显着推动了对空心胶囊的需求。

分段分析：透过检查以下分段对空胶囊市场进行分析：产品、功能、应用和最终用户。

就产品而言，空心胶囊市场分为明胶胶囊和非明胶胶囊。明胶胶囊在2022年占据了更大的市场份额，而非明胶胶囊预计在2022年至2030年期间的复合年增长率将达到9.0%。胶囊製造商青睐明胶，因为它能够促进药物快速释放和均匀混合，有助于防止药物分子氧化。然而，人们对动物产品过敏的担忧日益加剧，也推动了对非明胶胶囊的需求。此外，越来越多的纯素食者和素食者倾向于选择植物性替代品，预计未来几年该领域将迎来成长。

空心胶囊市场依功能分类，包括速释胶囊、缓释胶囊和缓释胶囊。速释胶囊在2022年占据了最大的市场份额，预计在预测期内将实现8.5%的最高复合年增长率。在抗酸药和抗菌抗生素的生产和包装领域，对速释胶囊的需求尤其高。 Nitta Gelatin India在2022年6月发表的一篇文章指出，速释胶囊疗法常用于治疗各种常见疾病和病症。

根据应用，空心胶囊市场分为抗生素和抗菌药物、维生素和膳食补充剂、抗酸剂和抗胀气製剂等。抗生素和抗菌药物部门在 2022 年占据最大市场份额，而维生素和膳食补充剂部门预计在 2022 年至 2030 年期间以 8.9% 的复合年增长率增长最快。抗生素和抗菌药物用于预防或治疗微生物感染。传染病发生率的上升、中低收入国家对抗生素的需求增加以及主要製药公司对研发的投资不断增加是推动抗生素和抗菌药物生产和包装对空心胶囊需求的关键因素。维生素和补充剂部门的成长归因于全球老龄人口的增长、对治疗药物的需求的增加以及营养补充剂对改善健康状况的日益普及。

依最终用户划分，空心胶囊市场可分为製药业、营养保健品产业、化妆品产业和研究实验室。製药业在2022年占据最大市场份额，预计2022年至2030年期间的复合年增长率最高，为8.4%。胶囊因其适口性较好、吸收较快而成为最常见的固体剂型。这些空心胶囊满足了製药业治疗各种慢性和传染病的严格要求。此外，製药业的进步，包括研发投入的增加、临床研究活动的开展以及胶囊给药技术的创新，预计将在预测期内支持该领域的成长。

区域分析：空胶囊市场报告涵盖北美、欧洲、亚太地区、中东和非洲以及南美和中美。 2022 年北美市场价值 18.3 亿美元，预计到 2030 年将达到 34.5 亿美元，2022 年至 2030 年的复合年增长率为 8.3%。北美空胶囊市场分为美国、加拿大和墨西哥。该地区的成长归因于人们对胶囊营养保健品配方的日益偏好，这些配方有助于缓解癌症、肥胖和关节炎等严重健康问题。慢性病盛行率的上升，尤其是在美国老年人口中，也促进了市场的成长。根据美国人口参考局发布的《人口公报：美国老化》，预计到2060年，65岁及以上美国人的数量将从2018年的5,200万增加近一倍，达到9,500万人。美国和加拿大完善的医疗保健体系吸引全球企业进入这些市场，从而催生了许多全球性企业的强劲发展。这些在该地区营运的国际公司满足了市场对空心胶囊的旺盛需求。

欧洲占据空心胶囊市场的第三大份额，其成长归因于疾病盛行率的上升、药物可及性的提高以及研发活动的增加。英国占欧洲空心胶囊市场的最大份额，而德国预计将在预测期内实现最快的成长。

预计 2022 年至 2030 年期间，亚太地区的全球空胶囊市场复合年增长率将最高。该地区的成长得益于可支配收入的增加和人们对营养补充剂日益增长的兴趣。随着气候条件的变化和劳动力的扩大，人们对护肤的意识不断增强，导致使用空的 HPMC 胶囊来封装精油、维生素和抗氧化剂等有效成分，从而促进了该地区空胶囊行业的发展。根据印度品牌股票基金的数据，印度美容和个人护理市场规模从 2019 年的 99.8 亿美元成长到 2021 年的 151 亿美元。因此，蓬勃发展的化妆品和製药业，尤其是韩国、印度、日本和中国，预计将在预测期内推动亚太地区空胶囊市场的成长。

空胶囊市场报告范围关键参与者分析：空胶囊市场报告中介绍的关键参与者包括 Erawat Pharma Limited、Sunil Healthcare、ACG Worldwide、Medi-Caps Ltd、Lonza Group (Capsugel)、Capscanada Corporation、Bright Pharma Caps Inc、Farmacapsulas、三菱化学控股公司 (Qualicaps, Inc.) 和 Roxlor LLC。

最新动态：市场参与者正在采取併购等策略。市场近期的一些发展包括：

2023年3月，ACG旗下子公司VANTAGE NUTRITION收购了美国ComboCap公司和南非BioCap公司，以增强其在北美及全球的技术和影响力。 2022年1月，西安乐纽特拉配料有限公司向欧洲拉脱维亚出口了800万粒HPMC胶囊，这些胶囊不含二氧化钛（TiO2），以响应欧盟委员会在食品添加剂中使用二氧化钛的禁令，彰显了该公司致力于满足区域需求的承诺。 2022年7月，Akums Drug & Pharmaceuticals Ltd.批准了其位于印度哈里德瓦尔的空硬明胶胶囊生产设施。这家总部位于欧盟的公司因遵守良好生产规范（GMP）而获得认可。 2022年2月，Lyfe Group旗下公司CapsCanada获得批准，其基于PLxGuard药物输送平台的液体填充阿斯匹灵胶囊可用于将药物输送到胃肠道的目标区域。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：空心胶囊市场概况

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：空心胶囊市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：空心胶囊市场 - 全球市场分析

  • 空心胶囊 - 全球市场概览
  • 空心胶囊－全球市场及2030年预测

第七章：空心胶囊市场-收入分析-依产品，2020-2030

  • 概述
  • 明胶胶囊
  • 非明胶胶囊
  • 其他的

第八章：空心胶囊市场-收入分析-依治疗应用，2020-2030

  • 概述
  • 抗生素和抗菌药物
  • 维生素和膳食补充剂
  • 抗酸剂和抗胀气剂
  • 其他的

第九章：空心胶囊市场-收入分析-按功能，2020-2030

  • 概述
  • 速释胶囊
  • 缓释胶囊
  • 缓释胶囊

第 10 章：空心胶囊市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 製药业
  • 营养保健品产业
  • 化妆品产业
  • 研究实验室

第 11 章：空心胶囊市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 13 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 14 章：空心胶囊市场 - 主要公司简介

  • Caps Canada
  • Sunil Healthcare
  • Farmacapsulas
  • Roxlor LLC
  • Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • Lonza Capsules and Health Ingredients
  • Bright Pharma Caps Inc
  • ACG Worldwide
  • Medi-Caps Ltd
  • Erawat Pharma Limited

第 15 章：附录

简介目录
Product Code: TIPRE00003411

The empty capsules market is anticipated to grow significantly, increasing from US$ 7.79 billion in 2024 to US$ 13.68 billion by 2031, with an estimated CAGR of 8.5% during the period from 2025 to 2031.

Analyst Perspective:This report outlines growth opportunities based on current trends in the empty capsules market and their expected effects throughout the forecast period. Key drivers of market growth include the rising elderly population, heightened demand for empty capsules across the pharmaceutical, nutraceutical, and cosmetic sectors, and a growing consumer preference for capsules over tablets. The elderly demographic, often dealing with chronic illnesses, is a primary focus for pharmaceutical manufacturers. Older adults tend to favor capsules because they are easier to swallow, dissolve faster, and cause less gastrointestinal discomfort. However, challenges such as increasing raw material costs and cultural or religious concerns regarding the animal-derived ingredients used in capsule production may impede market growth. Additionally, limited raw material availability, strict regulations for gelatin producers, and dietary restrictions also pose challenges to market expansion.

Market Overview:Factors propelling the growth of the empty capsules market include the rising acceptance of capsules as a preferred drug delivery method and strategic partnerships between capsule suppliers and gelatin manufacturers. Moreover, an increase in research and development activities, clinical trials, new product introductions, and advancements in capsule delivery technologies are expected to significantly influence the market forecast in the upcoming years. For example, in November 2019, Qualicaps, Inc. introduced a hard capsule dosage form at the CPHI WORLDWIDE 2019 conference.

Strategic Insights

Market Driver:Thriving Nutraceutical and Dietary Supplement Industries Fuel Market Expansion

A research study titled "The Nutraceutical Nexus: Unveiling The Complete Nutrient Solution In One Place" reported that the global nutraceuticals market was valued at US$ 454.55 billion in 2021 and is projected to grow at a CAGR of 9.0% from 2021 to 2030. Furthermore, the US International Trade Administration forecasts that India will represent approximately 3.5% of the global nutraceutical market value by 2023, with the Indian nutraceutical sector expected to expand from around US$ 4 billion in 2020 to US$ 18 billion by 2025. The nutraceutical and supplement industries provide vitamins, minerals, herbal extracts, probiotics, and other bioactive compounds, which often require encapsulation for convenient consumption. Empty capsules serve as an effective and adaptable delivery system for these ingredients, allowing manufacturers to create a variety of products. They enable manufacturers to customize formulations according to specific ingredients, dosages, and target demographics. This adaptability is crucial in the nutraceutical and dietary supplement sectors, where different products necessitate varying dosages and ingredient combinations. Consequently, capsules filled with nutraceuticals or dietary supplements help manufacturers fulfill consumer demands for quality, convenience, and efficacy, significantly driving the demand for empty capsules.

Segmental Analysis:The analysis of the empty capsules market has been conducted by examining the following segments: product, functionality, application, and end user.

In terms of product, the empty capsules market is divided into gelatin capsules and non-gelatin capsules. The gelatin capsules segment held a larger market share in 2022, while the non-gelatin capsules segment is projected to experience a higher CAGR of 9.0% from 2022 to 2030. The preference for gelatin among capsule manufacturers is due to its ability to facilitate rapid drug release and uniform drug mixing, which helps prevent the oxidation of drug molecules. However, increasing concerns regarding allergies to animal products have also driven demand for non-gelatin capsules. Additionally, the growing vegan and vegetarian population is leaning towards plant-based alternatives, leading to anticipated growth in this segment in the coming years.

The empty capsules market, categorized by functionality, includes immediate-release capsules, delayed-release capsules, and sustained-release capsules. The immediate-release capsules segment accounted for the largest market share in 2022 and is expected to achieve the highest CAGR of 8.5% during the forecast period. The demand for immediate-release capsules is particularly high in the manufacturing and packaging of antacids and antibacterial antibiotics. An article published by Nitta Gelatin India in June 2022 noted that therapeutics in immediate-release capsules are commonly prescribed for various prevalent diseases and disorders.

Based on application, the empty capsules market is segmented into antibiotics and antibacterial drugs, vitamins and dietary supplements, antacids and antiflatulent preparations, and others. The antibiotics and antibacterial drugs segment held the largest market share in 2022, while the vitamins and dietary supplements segment is expected to grow at the fastest CAGR of 8.9% from 2022 to 2030. Antibiotics and antibacterial drugs are used to prevent or treat microbial infections. The rising incidence of infectious diseases, increased demand for antibiotics in low- and middle-income countries, and growing investments in research and development by major pharmaceutical companies are key factors driving the demand for empty capsules in the manufacturing and packaging of antibiotics and antibacterial drugs. The growth of the vitamins and supplements segment is attributed to the expanding elderly population globally, rising demand for therapeutic drugs, and the increasing popularity of nutritional supplements for improved health outcomes.

By end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry segment held the largest market share in 2022 and is expected to register the highest CAGR of 8.4% from 2022 to 2030. Capsules are the most common solid dosage forms due to their improved palatability and faster absorption. These empty capsules fulfill the pharmaceutical industry's stringent requirements for treating various chronic and infectious diseases. Furthermore, advancements in the pharmaceutical sector, including increased R&D, clinical research activities, and technological innovations in capsule administration, are expected to support the growth of this segment during the forecast period.

Regional Analysis:The empty capsules market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American market was valued at US$ 1.83 billion in 2022 and is projected to reach US$ 3.45 billion by 2030, with an expected CAGR of 8.3% from 2022 to 2030. The North American empty capsules market is segmented into the US, Canada, and Mexico. The growth in this region is attributed to the increasing preference for capsule-based nutraceutical formulations that help mitigate serious health issues such as cancer, obesity, and arthritis. The rising prevalence of chronic diseases, particularly among the elderly population in the US, also contributes to market growth. According to the Population Reference Bureau's Population Bulletin: Aging in the US, the number of Americans aged 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. The well-established healthcare systems in the US and Canada encourage global market companies to enter these markets, resulting in a strong presence of numerous global players. The high demand for empty capsules is met by these international companies operating in the region.

Europe holds the third largest share of the empty capsules market, with growth attributed to the rising prevalence of diseases, improved drug accessibility, and increased research and development activities. The UK accounted for the largest share of the empty capsules market in Europe, while Germany is expected to experience the fastest growth during the forecast period.

The Asia Pacific region is projected to achieve the highest CAGR in the global empty capsules market from 2022 to 2030. The growth in this region is driven by rising disposable incomes and a growing interest in nutritional supplements. With changing climate conditions and an expanding workforce, there is a heightened awareness of skincare, leading to the use of empty HPMC capsules for encapsulating effective ingredients such as essential oils, vitamins, and antioxidants, thereby fostering the growth of the empty capsule industry in the region. According to the Indian Brand Equity Fund, the Indian beauty and personal care market grew to US$ 15.1 billion in 2021, up from US$ 9.98 billion in 2019. Consequently, the booming cosmetics and pharmaceutical industries, particularly in South Korea, India, Japan, and China, are expected to drive the growth of the empty capsules market in Asia Pacific during the forecast period.

Empty Capsules Market Report Scope

Key Player Analysis:Key players profiled in the empty capsules market report include Erawat Pharma Limited, Sunil Healthcare, ACG Worldwide, Medi-Caps Ltd, Lonza Group (Capsugel), Capscanada Corporation, Bright Pharma Caps Inc, Farmacapsulas, Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), and Roxlor LLC.

Recent Developments:Market participants are engaging in strategies such as mergers and acquisitions. Some recent developments in the market include:

In March 2023, VANTAGE NUTRITION, a subsidiary of ACG, acquired ComboCap, Inc. (US) and BioCap (South Africa) to enhance its technology and presence in North America and globally.In January 2022, Xi'an Le-Nutra Ingredients Inc. shipped 8.0 million HPMC capsules to Latvia, Europe, which were free from titanium dioxide (TiO2) following the European Commission's ban on TiO2 in food additives, demonstrating the company's commitment to meeting regional demand.In July 2022, Akums Drug & Pharmaceuticals Ltd. approved its empty hard gelatin capsule manufacturing facilities in Haridwar, India. This EU-based company is recognized for adhering to Good Manufacturing Practices (GMP).

In February 2022, CapsCanada, a Lyfe Group company, received approval for a liquid-filled aspirin capsule based on the PLxGuard drug delivery platform, designed to deliver medications to targeted areas of the gastrointestinal tract.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Empty Capsules Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Empty Capsules Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Empty Capsules Market - Global Market Analysis

  • 6.1 Empty Capsules - Global Market Overview
  • 6.2 Empty Capsules - Global Market and Forecast to 2030

7. Empty Capsules Market - Revenue Analysis (USD Million) - By Product, 2020-2030

  • 7.1 Overview
  • 7.2 Gelatin Capsules
    • 7.2.1 Porcine
    • 7.2.2 Bovine
    • 7.2.3 Bone
    • 7.2.4 Others
  • 7.3 Non-Gelatin Capsules
  • 7.4 Others

8. Empty Capsules Market - Revenue Analysis (USD Million) - By Therapeutic Application, 2020-2030

  • 8.1 Overview
  • 8.2 Antibiotic and Antibacterial Drugs
  • 8.3 Vitamins and Dietary Supplements
  • 8.4 Antacid and Antiflatulent Preparations
  • 8.5 Others

9. Empty Capsules Market - Revenue Analysis (USD Million) - By Functionality, 2020-2030

  • 9.1 Overview
  • 9.2 Immediate-Release Capsule
  • 9.3 Delayed-Release Capsules
  • 9.4 Sustained-Release Capsules

10. Empty Capsules Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 10.1 Overview
  • 10.2 Pharmaceutical Industry
  • 10.3 Nutraceutical Industry
  • 10.4 Cosmetics Industry
  • 10.5 Research Laboratories

11. Empty Capsules Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Empty Capsules Market Overview
    • 11.1.2 North America Empty Capsules Market Revenue and Forecasts to 2030
    • 11.1.3 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Product
    • 11.1.4 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Therapeutic Application
    • 11.1.5 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Functionality
    • 11.1.6 North America Empty Capsules Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Empty Capsules Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Empty Capsules Market
        • 11.1.7.1.1 United States Empty Capsules Market, by Product
        • 11.1.7.1.2 United States Empty Capsules Market, by Therapeutic Application
        • 11.1.7.1.3 United States Empty Capsules Market, by Functionality
        • 11.1.7.1.4 United States Empty Capsules Market, by End User
      • 11.1.7.2 Canada Empty Capsules Market
        • 11.1.7.2.1 Canada Empty Capsules Market, by Product
        • 11.1.7.2.2 Canada Empty Capsules Market, by Therapeutic Application
        • 11.1.7.2.3 Canada Empty Capsules Market, by Functionality
        • 11.1.7.2.4 Canada Empty Capsules Market, by End User
      • 11.1.7.3 Mexico Empty Capsules Market
        • 11.1.7.3.1 Mexico Empty Capsules Market, by Product
        • 11.1.7.3.2 Mexico Empty Capsules Market, by Therapeutic Application
        • 11.1.7.3.3 Mexico Empty Capsules Market, by Functionality
        • 11.1.7.3.4 Mexico Empty Capsules Market, by End User
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Empty Capsules Market - Key Company Profiles

  • 14.1 Caps Canada
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sunil Healthcare
  • 14.3 Farmacapsulas
  • 14.4 Roxlor LLC
  • 14.5 Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • 14.6 Lonza Capsules and Health Ingredients
  • 14.7 Bright Pharma Caps Inc
  • 14.8 ACG Worldwide
  • 14.9 Medi-Caps Ltd
  • 14.10 Erawat Pharma Limited

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud